Translation and Development of an Online Self-help Intervention With Subsequent Feasibility Study as an After Care After Inpatient Psychosomatic Treatment
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Treatment Satisfaction
- Sponsor
- Johannes Gutenberg University Mainz
- Enrollment
- 83
- Locations
- 1
- Primary Endpoint
- Satisfaction of the intervention group with the internet-based self-help program measured with an reworded version of the "patient satisfaction questionnaire" (ZUF-8)
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this study is to determine the feasibility and effectiveness of an internet-based self help program concerning satisfaction with the treatment and their life, depression and anxiety. Both study groups get access to the internet-based self-help program. The intervention group receives additional feedback to their progress in the program from an online therapist. The investigators hypothesize that (1) at least 75% of the patients in the intervention group are "satisfied" or "very satisfied" with the self-help program, (2) 50% of the patients in the intervention group work with all eight units and (3) patients of the intervention group have a higher emotional competence than the patients of the control group at the end of the self-help program.
Investigators
Dr. Rüdiger Zwerenz
Principle Investigator
Johannes Gutenberg University Mainz
Eligibility Criteria
Inclusion Criteria
- •day care/ inpatient treatment in the Department of Psychosomatic Medicine and Psychotherapy at the University Medical Center of the Johannes Gutenberg-University Mainz
- •minimum age of 18 years
- •private internet access
- •e-mail address
Exclusion Criteria
- •acute suicidality
- •psychosis
- •current alcohol or drug addiction
- •life time diagnosis of a schizophrenic, schizoaffective, bipolar or organic psychic disorder
Outcomes
Primary Outcomes
Satisfaction of the intervention group with the internet-based self-help program measured with an reworded version of the "patient satisfaction questionnaire" (ZUF-8)
Time Frame: 10 weeks after study inclusion (T1)
Secondary Outcomes
- Self-esteem measured with the German version of the "RSE" (Rosenberg Self-Esteem Scale)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Emotional competence measured with the "SEK-27" (questionnaire for self-assessment of emotional competence)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Quality of life measured with the German version of the "EUROHIS-QOL 8" (European Health Interview Survey Quality of Life 8)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Anxiety measured with the German version of the "GAD-7" (General Anxiety Disorder Screener)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Somatoform afflictions measured with the German version of the "SSS-8" (Somatic Symptom Scale)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Therapeutic alliance measured with the German version of the "WAI-SR" (Working Alliance Inventory - Short Revised)(10 weeks after study inclusion (T1))
- Depression measured with the German version of the "PHQ-9" (Patient Health Questionnaire)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Subjective prognosis of work ability measured with the "SPE" (Subjective Prognosis of Work Ability)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Acceptance of the internet-based self-help program measured with an especially for the self-help program devised questionnaire(End of every unit (weekly) and 10 weeks after study inclusion (T1))
- Usage of the internet-based self-help program measured with an especially for the self-help program devised questionnaire(10 weeks after study inclusion (T1))
- Depersonalisation measured with the German short version of the "CDS-2" (Cambridge Depersonalisation Scale)(10 weeks after study inclusion (T1) and 19 weeks after study inclusion (T2))
- Utilization of alternative after care measures (psychotherapy and drugs) with a self-devised questionnaire(10 weeks after study inclusion (T1))